| Title： | Expert consensus on prevention and treatment of SeDuGong (rheumatoid arthritis) with WA medicine |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | The users of this consensus include traditional Chinese medicine rheumatism, Western medicine rheumatism immunity, and ethnic medicine-related professional medical personnel, especially grass-roots Wa medical practitioners. |
| Evidence classification method： | According to the grading standard of clinical research evidence of traditional Chinese medicine: Level I: Randomized controlled trials and their systematic review, N-of-1 trial systematic review. Level II: non randomized clinical controlled trials, cohort studies, n-of-1 trials. Level III: case-control study, prospective case series. Level IV: standardized expert consensus, retrospective case series, historical controlled studies. Level V: non standardized expert consensus, case report, experience summary. |
| Development unit： | Yunnan Provincial Hospital of Traditional Chinese Medicine (The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine); Lincang Hospital of Traditional Chinese Medicine |
| Registration time: | 2024-07-30 |
| Registration number： | PREPARE-2024CN090 |
| Purpose of the guideline: | Rheumatoid Arthritis (RA) is a chronic and systemic autoimmune disease with erosive and symmetrical polyarthritis as the main clinical manifestations. It is a major and difficult disease in rheumatism. The etiology is complex, and there are many factors such as genetics, environment, sex hormones and so on. Close. The global prevalence rate of RA is 0.5%~1%, the prevalence rate in mainland China is 0.28~0.4%, and the prevalence rate between men and women is about 1:4. The disability rate of RA is 60% in 5-10 years, and the disability rate in 30 years is more than 90%. Common complications such as heart disease, interstitial lung disease, osteoporosis, etc., which seriously affect the patient's labor force and quality of life, and bring a heavy economic burden to the patient's family and society. The multi-angle excavation and collation of RA diagnosis and treatment methods for people Health is of great significance. Wa Medicine is one of the five major ethnic minority medicines in China, and has formed a relatively complete disease diagnosis and treatment system in the course of historical development. Wa medicine attributes rheumatoid arthritis into the category of "blocking the bow", which is a disease that causes pain, swelling, stiffness of muscles, limited movement, deformity and other major clinical manifestations due to the feeling of wind, cold, dampness, heat and other external evils. Wa medicine is widely used in the diagnosis and treatment of RA, which plays an important role in maintaining the health of the Wa people. However, the consensus of experts on the prevention and treatment of RA under the guidance of norms formulated in accordance with clinical diagnosis and treatment guidelines is still blank, and the methods and means of diagnosis and treatment of RA are difficult to be recognized and applied in clinical practice. Based on this, on the basis of analyzing and summarizing the existing research evidence, we fully consider the suggestions of authoritative units and experts in the field of Wa medicine and traditional Chinese medicine, and jointly formulate the Expert Consensus on the Prevention and Treatment of Color Blocking Bow (Rheumatoid Arthritis) of Wa Medicine, which aims to standardize the clinical diagnosis and treatment of Wa Medical RA and provide scientific and practical treatment suggestions for clinicians. , guide clinical decision-making and enhance the influence and recognition of Wa Pharmaceutical. |
Latest registration
